A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hereditary Hemochromatosis DNA Mutation Analysis
Test CodeHCHROMA
Quest Code
35079
Alias/See Also
35079
Alternative Name(s)
HLA-H
HFE
Hemochrom HFE Gene Analysis Blood
Hemochromatosis Hereditary DNA
H63D
Hemochromatosis
C282
CPT Codes
81256 (ZB0L5) **This test is not approved for New York patient testing. For New York patient testing, use test code 36193** (ZBOL5)
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Preferred Specimen
5 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
3 mL
Other Acceptable Specimens
ACD solution A (yellow-top) tube • ACD solution B (yellow-top) tube
Instructions
Whole blood: Normal phlebotomy procedure. Specimen stability is crucial. Store and ship room temperature immediately. Do not freeze.
Extracted DNA: Please call 1-866-GENE-INFO (1-866-436-3463) for additional information.
Extracted DNA: Please call 1-866-GENE-INFO (1-866-436-3463) for additional information.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 8 days
Refrigerated: 8 days
Frozen: Unacceptable
Refrigerated: 8 days
Frozen: Unacceptable
Methodology
Fluorescent Restriction Fragment Length Polymorphism • Polymerase Chain Reaction (PCR)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Monday-Saturday
Report Available
Reports in 8 days from receipt at QNI lab
Reference Range
See Laboratory Report
Clinical Significance
Hereditary Hemochromatosis is an autosomal recessive disease that results in an abnormal build-up of iron in the body. The C282Y and H63D are among the most common mutations in patients with hereditary hemochromatosis. Penetrance of the mutations (phenotypic disease), including by individuals with compound heterozygous mutations, is variable.
Performing Laboratory
Quest Diagnostics Nichols Institute
33608 Ortega Hwy
San Juan Capistrano, CA 92675-2042